TY - JOUR
T1 - Recommendations and guidelines for the treatment of pneumonia in Taiwan
AU - Infectious Diseases Society of Taiwan;
AU - Taiwan Society of Pulmonary and Critical Care Medicine,
AU - Medical Foundation in Memory of Dr. Deh-Lin Cheng;
AU - Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;
AU - CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,
AU - The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group
AU - Chou, Chih Chen
AU - Shen, Ching Fen
AU - Chen, Su Jung
AU - Chen, Hsien Meng
AU - Wang, Yung Chih
AU - Chang, Wei Shuo
AU - Chang, Ya Ting
AU - Chen, Wei Yu
AU - Huang, Ching Ying
AU - Kuo, Ching Chia
AU - Li, Ming Chi
AU - Lin, Jung Fu
AU - Lin, Shih Ping
AU - Ting, Shih Wen
AU - Weng, Tzu Chieh
AU - Wu, Ping Sheng
AU - Wu, Un In
AU - Lin, Pei Chin
AU - Lee, Susan Shin Jung
AU - Chen, Yao Shen
AU - Liu, Yung Ching
AU - Chuang, Yin Ching
AU - Yu, Chong Jen
AU - Huang, Li Ming
AU - Lin, Meng Chih
N1 - Funding Information:
This work was supported by Infectious Diseases Society of Taiwan (IDST), Taiwan, the Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), Taiwan. Funding was also provided from the Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan.
Funding Information:
This work was supported by Infectious Diseases Society of Taiwan (IDST), Taiwan, the Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), Taiwan. Funding was also provided from the Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan.
Publisher Copyright:
© 2019
PY - 2019/2
Y1 - 2019/2
N2 - Pneumonia is a leading cause of death worldwide, ranking third both globally and in Taiwan. This guideline was prepared by the 2017 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, formed under the auspices of the Infectious Diseases Society of Taiwan (IDST). A consensus meeting was held jointly by the IDST, Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), the Medical Foundation in Memory of Dr. Deh-Lin Cheng, the Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. The final guideline was endorsed by the IDST and TSPCCM. The major differences between this guideline and the 2007 version include the following: the use of GRADE methodology for the evaluation of available evidence whenever applicable, the specific inclusion of healthcare-associated pneumonia as a category due to the unique medical system in Taiwan and inclusion of recommendations for treatment of pediatric pneumonia. This guideline includes the epidemiology and recommendations of antimicrobial treatment of community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia in adults and pediatric pneumonia.
AB - Pneumonia is a leading cause of death worldwide, ranking third both globally and in Taiwan. This guideline was prepared by the 2017 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, formed under the auspices of the Infectious Diseases Society of Taiwan (IDST). A consensus meeting was held jointly by the IDST, Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), the Medical Foundation in Memory of Dr. Deh-Lin Cheng, the Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. The final guideline was endorsed by the IDST and TSPCCM. The major differences between this guideline and the 2007 version include the following: the use of GRADE methodology for the evaluation of available evidence whenever applicable, the specific inclusion of healthcare-associated pneumonia as a category due to the unique medical system in Taiwan and inclusion of recommendations for treatment of pediatric pneumonia. This guideline includes the epidemiology and recommendations of antimicrobial treatment of community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia in adults and pediatric pneumonia.
UR - http://www.scopus.com/inward/record.url?scp=85059437821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059437821&partnerID=8YFLogxK
U2 - 10.1016/j.jmii.2018.11.004
DO - 10.1016/j.jmii.2018.11.004
M3 - Letter
C2 - 30612923
AN - SCOPUS:85059437821
SN - 1684-1182
VL - 52
SP - 172
EP - 199
JO - Journal of Microbiology, Immunology and Infection
JF - Journal of Microbiology, Immunology and Infection
IS - 1
ER -